Recursion Pharmaceuticals, Inc. (RXRX)
3.115
+0.06
(+1.80%)
USD |
NASDAQ |
Apr 02, 16:00
3.11
0.00 (0.00%)
After-Hours: 16:10
Recursion Pharmaceuticals Research and Development Expense (TTM) : 425.27M for Dec. 31, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Intellia Therapeutics, Inc. | 379.07M |
| Tango Therapeutics, Inc. | 130.51M |
| Hims & Hers Health, Inc. | 149.30M |
| Novavax, Inc. | 338.72M |
| Geron Corp. | 73.72M |